Fig. 1.

Study design. *CZP monotherapy analysis excludes 1 FAST4WARD patient who was receiving MTX at baseline—patients were excluded from the CZP monotherapy analysis from the date of concomitant MTX administration. ^†CZP+MTX group includes all patients from Study 014 and one patient from FAST4WARD study who received MTX at baseline